A sugar present on virus envelopes might become the target of new antiviral treatments for a range of viruses, researchers report August 27 in Science Advances. This treatment, shown to shut down infections of Ebola, Nipah, SARS-CoV-2 and other viruses in mice, could potentially be the first line of defense against future pandemics, the scientists say.
“This is an interesting study, showing a possible pathway towards broad-spectrum antivirals,” says William Wimley, a biochemist at Tulane University School of Medicine in New Orleans, who wasn’t part of the study. “But there are still many optimization steps before we get there.”
.email-conversion { border: 1px solid #ffcccb; color: white;→ Continue reading at Science News